Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PC-GROW
- Development stage
- Unknown
- Lead developer
- Allgems Healthcare
- Administration
- Oral
01
Overview
PC-GROW is an herbal supplement developed by Allgems Healthcare, primarily indicated for platelet support and the management of thrombocytopenia (low platelet count). It is categorized within the company's portfolio as an herbal platelet support product and is marketed as a branded generic/nutraceutical. The formulation is intended to assist in increasing and maintaining healthy platelet levels, which is a common clinical requirement during viral infections such as dengue fever or other conditions where thrombocyte production is compromised. PC-GROW is administered orally and is currently approved and available on the market as a supportive therapy.
- Brand names
- PC-GROW
Beyond the preview
Go deeper on PC-GROW.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PC-GROW.